AI is central to GE HealthCare’s digital strategy, which focuses on its precision care framework that includes smart devices, targeted therapies, a disease-specific focus, and digital solutions, with a commitment to solving the growing data challenge in patient care and using that data to help providers optimize care.
GE HealthCare leads a U.S. FDA list of AI-enabled medical devices with 58 listed 510(k) clearances or approvals to date in the United States, including Sonic DL for faster MRI scans, Auto Segmentation for streamlined radiation therapy workflow, and Precision DL for enhanced small, low-contrast lesion detectability compared to conventional Time-of-Flight PET/CT scanner.
The company will showcase several AI-enabled products at RSNA 2023, as well as its App Orchestrator, an application orchestration solution that gives customers easy access to multiple applications from multiple companies, and CardioVisio, a first-of-its-kind AFiB patient management dashboard designed to save time, improve clinical confidence, and deliver precision care. GE HealthCare is also collaborating with Nuance and Microsoft on a research technology project that is intended to automatically assembles relevant prior studies/reports and summarizes significant content for radiologists in the imaging workflow.
We’re harnessing the power of digital technology and AI to create seamless, intuitive, and intelligent tools that are designed to empower clinicians to deliver high-quality, personalized care. Our vision is a solution that provides a centralized, longitudinal view of the patient, connecting data in and out of the hospital, and providing real-time insights that inform treatment decisions,” said Dr. Taha Kass-Hout, Chief Technology Officer of GE HealthCare.
To view the source version, please click HERE.